EasyMed Services SA announced that the Dow Chemical Company has signed for a trial of the international medical passport for its executive staff in France. The international medical passport is viewed as an excellent added-value benefit for the company's executives, particularly considering the company's customers in 160 countries. The trial will be implemented as a first step to allow staff to securely download their medical files on to their Smartphone.

The company primary focus is to rise to the opportunity presented by the French initiative towards the adoption of mobile health records.